Or, they do, but the body isnt able to absorb enough vitamin B12 from food
Marc Jean-Gilles, DO, FACOG , provides personalized guidance throughout this process, ensuring that each patients experience is carefully monitored
The Rising Challenge of DM2 and Obesity The global burden of DM2 presented a significant concern in 2019, with an estimated 9.3% prevalence, equating to 463 million individuals affected
Schoretsanitis and Gastaldon found that patients who are co-prescribed antidepressants and the GLP-1 agonist semaglutide may be at risk of developing suicidal ideation
Gastric electrical stimulation as therapy of morbid obesity: preliminary results from the French study
Environmental and behavioral factors compound the plateau effect